Sign In
Buy AMPE
$0.183
+0 (+0%)
At Close: Jun 03, 2026
Hot Penny Stocks to Buy? 3 to Watch As Vaccine Rates Hit New Highs
09:27am, Wednesday, 16'th Jun 2021
Best penny stocks to watch with vaccine rates higher than ever The post Hot Penny Stocks to Buy? 3 to Watch As Vaccine Rates Hit New Highs appeared first on Penny Stocks to Buy, Picks, News and Inform
Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India
06:15am, Tuesday, 15'th Jun 2021
ENGLEWOOD, Colo., June 15, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamm
Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo
06:15am, Monday, 14'th Jun 2021
ENGLEWOOD, Colo., June 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pr
Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual Summer Healthcare Symposium
09:15am, Friday, 11'th Jun 2021
ENGLEWOOD, Colo., June 11, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pr
Ampio Pharmaceuticals: Regulatory Process Taking Too Long
03:31am, Sunday, 23'rd May 2021
Ampio has existed for over a decade, and run more than a dozen trials for lead asset Ampion. Regulatory path is still unclear for osteoarthritis of the knee.
Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
09:15am, Friday, 21'st May 2021
ENGLEWOOD, Colo., May 21, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pre
Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)
09:15am, Monday, 10'th May 2021
ENGLEWOOD, Colo., May 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammat
Ampio Pharmaceuticals, Inc. (AMPE) CEO Mike Macaluso on Q1 2021 Results - Earnings Call Transcript
11:19am, Friday, 07'th May 2021
Ampio Pharmaceuticals, Inc. (AMPE) CEO Mike Macaluso on Q1 2021 Results - Earnings Call Transcript
Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
04:01pm, Wednesday, 05'th May 2021
ENGLEWOOD, Colo., May 5, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma
Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%
09:15am, Tuesday, 27'th Apr 2021
ENGLEWOOD, Colo., April 27, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflam
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update
09:15am, Wednesday, 21'st Apr 2021
ENGLEWOOD, Colo., April 21, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflam
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects
09:15am, Monday, 19'th Apr 2021
ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflam
Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
09:15am, Tuesday, 06'th Apr 2021
ENGLEWOOD, Colo., April 6, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma
Ampio Pharmaceuticals is Building on its Progress in Tackling Osteoarthritis and COVID-19 Respiratory Issues
09:57am, Thursday, 01'st Apr 2021
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, presented March
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
09:15am, Monday, 29'th Mar 2021
ENGLEWOOD, Colo., March 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pr
